Yu‐Wei Lin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Antibiotic Resistance in Bacteria 19
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 13
- Co-authors
- Jian Li (21 shared papers)Christian G. Bucher (1 shared paper)Tony Velkov (17 shared papers)Yan Zhu (13 shared papers)Qi Tony Zhou (11 shared papers)Mei‐Ling Han (11 shared papers)Darren J. Creek (7 shared papers)Gauri G. Rao (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)International Journal of Antimicrobial Agents (3 papers)Frontiers in Pharmacology (3 papers)Computational and Structural Biotechnology Journal (2 papers)Pharmaceutical Research (2 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
Yu‐Wei Lin
35 papers receiving 843 citations
Yu‐Wei Lin's Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Medicine 304
- Microbiology 112
- Applied Microbiology and Biotechnology 26
- Endocrinology 53
- Pharmacology 116
Countries citing papers authored by Yu‐Wei Lin
This map shows the geographic impact of Yu‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wei Lin more than expected).
Fields of papers citing papers by Yu‐Wei Lin
This network shows the impact of papers produced by Yu‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wei Lin. The network helps show where Yu‐Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation Hit paper breakdown → | 2023 | 107 |
| 2 | 1989 | 95 | |
| 3 | 2019 | 62 | |
| 4 | 2019 | 62 | |
| 5 | 2018 | 56 | |
| 6 | 2018 | 54 | |
| 7 | 2020 | 45 | |
| 8 | 2017 | 44 | |
| 9 | 2018 | 40 | |
| 10 | 2020 | 24 | |
| 11 | 2018 | 21 | |
| 12 | 2019 | 21 | |
| 13 | 2022 | 21 | |
| 14 | 2019 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2018 | 19 | |
| 17 | 2020 | 19 | |
| 18 | 2023 | 19 | |
| 19 | 2022 | 17 | |
| 20 | 2018 | 15 |
About Yu‐Wei Lin
Yu‐Wei Lin is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Epidemiology and Ecology, having authored 38 papers that have together received 861 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Tuberculosis Research and Epidemiology (5 papers), Pneumonia and Respiratory Infections (5 papers), Plant Water Relations and Carbon Dynamics (4 papers), Ecology and Vegetation Dynamics Studies (3 papers), Bacteriophages and microbial interactions (3 papers) and Inhalation and Respiratory Drug Delivery (2 papers). The work is most often cited by research in Molecular Medicine (304 citations), Microbiology (112 citations), Applied Microbiology and Biotechnology (26 citations), Endocrinology (53 citations) and Pharmacology (116 citations). Yu‐Wei Lin has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Jian Li, Christian G. Bucher, Tony Velkov, Yan Zhu, Qi Tony Zhou, Mei‐Ling Han, Darren J. Creek, Gauri G. Rao, Hak‐Kim Chan and Sue C. Nang. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents, Frontiers in Pharmacology, Computational and Structural Biotechnology Journal and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.